Skip to main content
. 2019 Jan 3;24(1):1700818. doi: 10.2807/1560-7917.ES.2019.24.1.1700818

Figure 4.

Seroprotection against serogroup C meningococci measured by proportions with serum bactericidal antibody (SBA) titres of ≥ 8

SBA: serum bactericidal antibody.

Comparison of levels in 2014 with the previous surveys conducted before MenC conjugate vaccine introduction in 1996–99 and following introduction in 2000–04 and 2009.

Figure 4